Yatsen Results Presentation Deck
Continuous Investment in R&D
R&D Expenses as % of Net Revenues
1.3%
R&D Investment
FY2020
RMB 127MM
in FY2022
2.4%
FY2021
3.4%
FY2022
RMB 335MM
since FY2020
2022.02
2022.06
2022.09
2022.11
2022.11
2023.03
中山大学医学院
干细胞代谢及衰老研究平台
张宏波教授
· 细胞衰老及基于代谢的衰老延缓机制
· 揭示线粒体代谢调控干细胞命运的机制
* Science 等顶尖期刊发表研究论文27篇,篇
19IF: 23.2
R&D Milestones
The nano-targeting technology that we developed along with
Huazhong University of Science and Technology was
applied to DR.WU's new product, Triple Action Repair Serum
Our R&D center was CNAS certified
We debuted at the IFSCC Congress with two R&D findings
We joined hands with Sun Yat-sen University to release the latest
results of the Chinese Skin Aging Research Platform
中山大学药学院
创新微生物产品开发平台
We debuted the latest innovations of Galénic and Eve Lom at the
5th China International Import Expo
Ms. Jing Cheng was appointed our Chief Scientific Officer
张雄教授
·商学院微生物与生化制药教研室主任
·擅长于微生物学,益生菌制剂等
・丰富的临床微生物检验及活菌药品研究经验
中山大学第一附属医院
再生医学研究平台
PARE-
祁少海副院长
• 中国医师协会烧伤科医师分会副会长
YSG 逸仙
· 擅长于烧伤,难念、复杂面的修复
陈教授
· 现任中山大学附第一医院副主任医师
·擅长创面微环境,皮肤再生和抗衰机制
YSC
YSO
12View entire presentation